A pilot trial with clenbuterol in amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis

Volumn 7, Issue 4, 2006, Pages 252-254

  Sorarù, Gianni ^a,b   Pegoraro, Elena ^a   Spinella, Paolo ^a   Turra, Silvia ^a   D'Ascenzo, Carla ^a   Baggio, Linda ^a   Mantovan, Maria Cristina ^a   Vergani, Lodovica ^a   Angelini, Corrado ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Piove di Sacco   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Clenbuterol; Skeletal muscle; Therapy; Trial

Indexed keywords

CLENBUTEROL; RILUZOLE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; BODY COMPOSITION; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; DISEASE COURSE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; ELECTROLYTE DISTURBANCE; FASCICULATION; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTION TEST; HAND TREMOR; HEART PALPITATION; HUMAN; IMPEDANCE; LETTER; MALE; MUSCLE CRAMP; MUSCLE FUNCTION; MUSCLE MASS; NERVOUSNESS; PATIENT COMPLIANCE; PILOT STUDY; PRIORITY JOURNAL; RESPIRATORY FAILURE; SIDE EFFECT; SPINE DISEASE; TACHYCARDIA; ARTICLE; MIDDLE AGED; TREATMENT OUTCOME;

ADRENERGIC BETA-AGONISTS; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; CLENBUTEROL; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 33847231900     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/14660820600600558     Document Type: Letter

References (13)

1. Swash, M. (2000) Clinical features and diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis, p. 330. Martin Dunitz, London
2. Hinkle, R. T., Hodge, K. M., Cody, D. B., Sheldon, R. J., Kobilka, B. K. and Isfort, R. J. (2002) Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by beta 2-adrenergic receptor. Muscle Nerve, 25, pp. 729-734.
3. Fukumoto, H., Kakihana, M. and Suno, M. (1994) Characterization of C6-10A glioma cells highly responsive to beta adrenergic receptor agonist induced NGF synthesis/secretion. Glia, 12, pp. 151-160.
4. Semkova, I., Schilling, M., Henrich-Noack, P., Rami, A. and Krieglstein, J. (1996) Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischaemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF. Brain Res, 717, pp. 44-54.
5. Uc, E. Y., Dienel, G. A., Cruz, N. F. and Harik, S. I. (2002) Adrenergics enhance brain extraction of levodopa. Mov Disord, 17, pp. 54-59.
6. Agbenyega, E. D. and Wareham, A. C. (1990) Effect of clenbuterol on normal and denervated muscle growth and contractility. Muscle Nerve, 13, pp. 199-203.
7. Maltin, C. A., Delday, M. I., Watson, J. S., Heys, S. D., Nevison, I. M. and Ritchie, I. K. (1993) Clenbuterol, a beta adrenoreceptor agonist, increases relative muscle strenghth in orthopaedic patients. Clin Sci, 4, pp. 651-654.
8. Kinali, M., Mercuri, E., Main, M., De Biasia, F., Karatza, A. and Higgins, R. (2002) Pilot trial with albuterol in spinal muscular atrophy. Neurology, 59, pp. 609-610.
9. Juhasz-Pocsine, K., Merryfield, J. J., Sanjak, M., Belden, D. S., Waclawik, A. J. and Brooks, B. R. (1999) Beta 2-adrenergic agonist (Albuterol) ergotropic effect on neck extension (NE) and neck flexion (NF) maximal voluntary isometric contraction (MVIC) strength in amyotrophic lateral sclerosis (ALS) patients: Quasi-experimental prospective non-randomized control pilot studies using Medical Research Council (MRC) grading scale and computerized isometric muscle testing (CIMT). Neurology, 526, p. A526.
10. Signorile, J. F., Banovac, K., Gomez, M., Flipse, D., Caruso, J. F. and Lowensteyn, I. (1995) Increased muscle strength in paralysed patients after spinal cord injury: Effect of beta 2-adrenergic agonists. Arch Phys Med Rehabil, 76, pp. 55-58.
11. World Federation of Neurology Research Committee on Neuromuscular Diseases and Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis (1994) El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci, 124, pp. 96-107.
12. Cedarbaum, J. M. and Stambler, N. (1997) Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicentre clinical trials. J Neurol Sci, 152, p. S1.
13. Frisancho, A. R. and Flegel, P. N. (1982) Relative merits of old and new indices of body mass with reference to skin-folds thickness. Am J Clin Nutr, 36, pp. 697-699.